Abstract

REVOLUTIONISE HEALTHCARE THROUGH REGENERATIVE MEDICINE AND CURRENT ARDOUS

Twinkle Vaja*

ABSTRACT

Despite the fact that Regenerative Medicine has been one of the most popular areas in biotechnology for the past three decades, this may be due to the novelty and disruptiveness ofthese technologies, which have made translation more difficult. Therefore, we explore how thetranslational strategy has transformed history in the Regenerative Medicine sector. The study shows how the pursuit of such novel regenerative therapies has altered how experts aim to translate their concepts into clinical applications, and then we identify areas that need to be improved or corrected in order for these therapies to eventually be incorporated into the standard of care. Inthis article, we will describe how regenerative medicine plays a significant role in the healthcaresystem. This article encourages legislative, regulatory, reimbursement, and manufacturing initiatives to advance this innovative and transformative field. In order to ensure patient access;it will address the arduous of pre-clinical trials, clinical trials, and manufacturing of regenerative medicines; and developing resources, standards, skills, manufacturing infrastructure, education, training, and workforce development for better services and assess the value of healthcare. This is followed by a discussion of the current issues, which will contribute to the future progression of Regenerative Medicine.

Keywords: Regenerative medicine, Revolunise healthcare, Regulatory challenges, Unapproved cell intervention.